Co-Diagnostics, Inc. Reports Its COVID-19 PCR Assays Unaffected by Omicron Variant
Co-Diagnostics, Inc. has reported that none of the mutations in the Omicron SARS-CoV-2 variant will interfere with any of the company’s COVID-19 tests.
Read MorePosted by Chris Wolski | Nov 29, 2021 | Covid 19, Immunoassay Reagents & test Kits |
Co-Diagnostics, Inc. has reported that none of the mutations in the Omicron SARS-CoV-2 variant will interfere with any of the company’s COVID-19 tests.
Read MorePosted by Chris Wolski | Nov 29, 2021 | Covid 19, POC Reagents & Test Kits |
BioReference Laboratories, Inc., an OPKO Health company, has announced that it is prepared for COVID-19 testing for the Omicron Variant.
Read MorePosted by Andy Lundin | Nov 29, 2021 | Covid 19, POC Reagents & Test Kits |
A new COVID-19 tracking software can streamline employee compliance with OSHA standards, allowing for testing that can be self-administered and self-read.
Read MorePosted by Andy Lundin | Nov 25, 2021 | Covid 19, POC Reagents & Test Kits |
COVID-19 saliva testing kits that include a novel preservative can help with the study of the relationship between oral microbes and the SARS-CoV-2 virus.
Read MorePosted by Andy Lundin | Nov 25, 2021 | Covid 19, Immunoassay Reagents & test Kits |
A novel test from AEGEA is highly sensitive and specific, and can quantify a patient’s SARS-CoV-2 viral load to determine the active infection level.
Read More